| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC | 3 |
| 1 | DICLOFENAC SODIUM | 3 |
| 2 | FLUOXETINE HYDROCHLORIDE | 3 |
| 3 | GABAPENTIN | 3 |
| 4 | ASPIRIN | 2 |
| 5 | ASPIRIN 325 MG | 2 |
| 6 | ASPIRIN 81 MG | 2 |
| 7 | AZILSARTAN KAMEDOXOMIL | 2 |
| 8 | AZILSARTAN MEDOXOMIL | 2 |
| 9 | BELIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 1 | POTASSIUM ACETATE | 1 | 0.0007 |
| 2 | AZILSARTAN KAMEDOXOMIL | 2 | 0.0007 |
| 3 | ADENOSINE | 1 | 0.0006 |
| 4 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 5 | ATROPINE SULFATE INJECTION | 1 | 0.0004 |
| 6 | ATROPINE SULFATE MONOHYDRATE | 1 | 0.0004 |
| 7 | TRIPTORELIN PAMOATE | 1 | 0.0004 |
| 8 | TIROFIBAN | 1 | 0.0003 |
| 9 | CALCIUM CHLORIDE INJECTION | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 1 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 2 | Intestinal Lipase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 7 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Antirheumatic Agent [EPC] | 2 | 0.0000 |